Eurofins Scientific: Weak Organic Growth Cyclical, Growth Will Normalize
Source: SeekingAlpha
2026-02-02 19:05:00 ET
The following segment was excerpted from the Sequoia Fund ( SEQUX ) Q4 2025 Shareholder Letter. ...
Read the full article on Seeking Alpha
For further details see:
Eurofins Scientific: Weak Organic Growth Cyclical, Growth Will Normalize
Eurofins Scientific S.E.
NASDAQ: ERFSF
ERFSF Trading
-3.21% G/L:
$73.19 Last:
535 Volume:
$71.91 Open:
ERFSF Latest News
March 11, 2026 04:00:00 am
Eurofins Biomnis Launches New Clinical LC?MS/MS Method for the Detection of Cereulide Toxin in Stool Samples
February 05, 2026 10:30:00 am
Eurofins CDMO Alphora Joins International Consortium Project to Advance Next Generation ADC Expression Platform
